US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Papaverine 30mg/Phentolamine 2mg/Prostaglandin 20mcg/mL

Reason Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.

Vitalab Pharmacy, Inc D-0733-2018
Class II · Moderate risk Terminated

Papaverine 30mg/Phentolamine 1.5mg/Prostaglandin 50mcg/mL

Reason Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.

Vitalab Pharmacy, Inc D-0732-2018
Class II · Moderate risk Terminated

Methionine 25mg/Inositol 50mg/Choline 50mg/Cyanocobalamin 1mg/ml

Reason Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.

Vitalab Pharmacy, Inc D-0731-2018
Class II · Moderate risk Terminated

Papaverine 9mg/Phentolamine 1mg/Atropine 0.1mg/Prostaglandinl 10mcg/ml

Reason Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.

Vitalab Pharmacy, Inc D-0730-2018
Class II · Moderate risk Terminated

Alprostadil 20 mcg/mL

Reason Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.

Vitalab Pharmacy, Inc D-0729-2018
Class II · Moderate risk Terminated

Methylcobalamin for injection

Reason Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.

Vitalab Pharmacy, Inc D-0728-2018
Class II · Moderate risk Terminated

Metoprolol Succinate Extended-Release Tablets

Reason Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets.

Dr. Reddy's Laboratories, Inc. NDC 55111-468-01 D-0727-2018
Class II · Moderate risk Terminated

Sulfamethoxazole and Trimethoprim Tablets USP

Reason Presence of Foreign Substance:Sun Pharma is recalling one (1) lot of Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg (500 ct.) because a foreign matter identified as polyethylene was detected in two (2) tablets.

Sun Pharmaceutical Industries, Inc. NDC 53489-146-05 D-0802-2018
Class II · Moderate risk Terminated

NEOstigmine Methylsulfate

Reason Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Premier Pharmacy Labs Inc NDC 69623-234-14 D-0702-2018
Class II · Moderate risk Terminated

Hydromorphone HCl 1 mg/mL PF INJ. 1mL in a 3mL Sterile…

Reason Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Premier Pharmacy Labs Inc NDC 69623-249-10 D-0701-2018
Class II · Moderate risk Terminated

Morphine Sulfate 4 mg/mL PF Injection. 1 mL in a 3ml Sterile…

Reason Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Premier Pharmacy Labs Inc NDC 69623-127-10 D-0700-2018
Class II · Moderate risk Terminated

Morphine Sulfate 2 mg/mL PF Injection. 1 mL in a 3ml Sterile…

Reason Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Premier Pharmacy Labs Inc NDC 69623-129-10 D-0699-2018
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Out of specification for adhesive transfer.

Noven Pharmaceuticals, Inc. NDC 68968-5552-3 D-0627-2018